Cyclosporine potentially effective as off-label anti-inflammatoryHealioPHOENIX – Clinicians reported in a poster here at Academy 2012 that cyclosporine 0.05% emulsion, with its safety and minimal side effect profiles, should be considered in cases wh…
mTOR inhibitors Tank in Three Advanced Kidney Cancer TrialsThe Oncology ReportVIENNA – The mammalian target of rapamycin inhibitors temsirolimus and everolimus have racked up a trio of negative trials in advanced renal cell carcinoma. The phase IIIb …
Platinum todayPromus platinum stent successful in long coronary lesion treatmentPlatinum todayBoston Scientific Corporation says its Promus Element Everolimus-Eluting Platinum Chromium Stent System has been effective in treating patients with long coro…
Micell Technologies Announces Positive Data from Clinical Studies of MiStent SESSacramento BeeDURHAM, N.C., Oct. 23, 2012 — /PRNewswire/ — Micell Technologies, Inc. today announced positive data from two clinical studies of its investigational MiSten…
Absolute latest data on the fungal meningitis outbreak: Oct 22, 2012Examiner.comFour weeks previously (3 weeks prior to the first headaches) he had received the latest in a series of epidural injections of corticosteroids from his orthopedic surgeon fo…
The Boston Scientific PROMUS Element™ Platinum Chromium Stent …Sacramento Bee"This durable polymer everolimus-based stent, built on the advanced platinum chromium platform, demonstrated low rates of revascularization while reporting no myocard…
Boston Scientific Says Epic Stent Continues Positive Clinical OutcomesBenzingaBoston Scientific Corporation (NYSE: BSX) reports clinical endpoint data from the PLATINUM Long Lesion trial, demonstrating positive outcomes for the PROMUS Element™ Everol…
TCTMDMeta-Analyses Show Improved Outcomes with DES vs. BMSTCTMDOne pooled study showed improved rates of late stent thrombosis with cobalt-chromium everolimus-eluting stents, and another found excellent clinical outcome results with second-generation D…
New study could lessen asthmatics reliance on inhalersCatholic OnlineLOS ANGELES, CA (Catholic Online) – The medicine commonly fond in those inhalers are corticosteroids, which open airways and decreases mucus so it's easier to breathe. Inhaled cor…
OncLiveTargeted Therapies in Advanced Renal Cell Cancer: A Critical ReviewOncLiveSo far, two mTOR inhibitors, temsirolimus and everolimus, have been approved and widely characterized for treatment of advanced RCC. These agents lead to G1 growth arrest …